119 related articles for article (PubMed ID: 21744351)
41. Mitogenic action of LPA in prostate.
Daaka Y
Biochim Biophys Acta; 2002 May; 1582(1-3):265-9. PubMed ID: 12069837
[TBL] [Abstract][Full Text] [Related]
42. Signal transduction responses to lysophosphatidic acid and sphingosine 1-phosphate in human prostate cancer cells.
Gibbs TC; Rubio MV; Zhang Z; Xie Y; Kipp KR; Meier KE
Prostate; 2009 Oct; 69(14):1493-506. PubMed ID: 19536794
[TBL] [Abstract][Full Text] [Related]
43. Specific LPA receptor subtype mediation of LPA-induced hypertrophy of cardiac myocytes and involvement of Akt and NFkappaB signal pathways.
Chen J; Chen Y; Zhu W; Han Y; Han B; Xu R; Deng L; Cai Y; Cong X; Yang Y; Hu S; Chen X
J Cell Biochem; 2008 Apr; 103(6):1718-31. PubMed ID: 17891781
[TBL] [Abstract][Full Text] [Related]
44. Lysophosphatidic acid induces clonal generation of mouse neurospheres via proliferation of Sca-1- and AC133-positive neural progenitors.
Svetlov SI; Ignatova TN; Wang KK; Hayes RL; English D; Kukekov VG
Stem Cells Dev; 2004 Dec; 13(6):685-93. PubMed ID: 15684836
[TBL] [Abstract][Full Text] [Related]
45. Toward the three-dimensional structure and lysophosphatidic acid binding characteristics of the LPA(4)/p2y(9)/GPR23 receptor: a homology modeling study.
Li G; Mosier PD; Fang X; Zhang Y
J Mol Graph Model; 2009 Aug; 28(1):70-9. PubMed ID: 19423373
[TBL] [Abstract][Full Text] [Related]
46. A growing family of receptor genes for lysophosphatidic acid (LPA) and other lysophospholipids (LPs).
Chun J; Contos JJ; Munroe D
Cell Biochem Biophys; 1999; 30(2):213-42. PubMed ID: 10356643
[TBL] [Abstract][Full Text] [Related]
47. Lysophosphatidic acid-stimulated interleukin-6 and -8 synthesis through LPA1 receptors on human osteoblasts.
Aki Y; Kondo A; Nakamura H; Togari A
Arch Oral Biol; 2008 Mar; 53(3):207-13. PubMed ID: 17915188
[TBL] [Abstract][Full Text] [Related]
48. Lysophosphatidic acid and sphingosine 1-phosphate metabolic pathways and their receptors are differentially regulated during decidualization of human endometrial stromal cells.
Brünnert D; Sztachelska M; Bornkessel F; Treder N; Wolczynski S; Goyal P; Zygmunt M
Mol Hum Reprod; 2014 Oct; 20(10):1016-25. PubMed ID: 24994816
[TBL] [Abstract][Full Text] [Related]
49. A role for G protein-coupled lysophospholipid receptors in sphingolipid-induced Ca2+ signaling in MC3T3-E1 osteoblastic cells.
Lyons JM; Karin NJ
J Bone Miner Res; 2001 Nov; 16(11):2035-42. PubMed ID: 11697799
[TBL] [Abstract][Full Text] [Related]
50. Effects of LPA receptor-mediated signaling on the modulation of cellular functions of pancreatic cancer cells cultured in fibroblast supernatants under hypoxic conditions.
Takai M; Okuda A; Amano Y; Yashiro N; Hara K; Yamamoto M; Tsujiuchi T
J Bioenerg Biomembr; 2023 Jun; 55(3):169-177. PubMed ID: 37219648
[TBL] [Abstract][Full Text] [Related]
51. Overexpression of edg-2/vzg-1 induces apoptosis and anoikis in ovarian cancer cells in a lysophosphatidic acid-independent manner.
Furui T; LaPushin R; Mao M; Khan H; Watt SR; Watt MA; Lu Y; Fang X; Tsutsui S; Siddik ZH; Bast RC; Mills GB
Clin Cancer Res; 1999 Dec; 5(12):4308-18. PubMed ID: 10632375
[TBL] [Abstract][Full Text] [Related]
52. LPA receptor-mediated signaling regulates cell motility and survival to anticancer drug of pancreatic cancer cells under glucose-deprived and hypoxic conditions.
Takai M; Takauchi M; Kuribayashi M; Tsujiuchi T
Biochem Biophys Res Commun; 2023 Jun; 661():21-27. PubMed ID: 37084489
[TBL] [Abstract][Full Text] [Related]
53. Utilization of the Tango beta-arrestin recruitment technology for cell-based EDG receptor assay development and interrogation.
Wetter JA; Revankar C; Hanson BJ
J Biomol Screen; 2009 Oct; 14(9):1134-41. PubMed ID: 19726785
[TBL] [Abstract][Full Text] [Related]
54. Potential role of EDG receptors and lysophospholipids as their endogenous ligands in the respiratory tract.
Racké K; Hammermann R; Juergens UR
Pulm Pharmacol Ther; 2000; 13(3):99-114. PubMed ID: 10873548
[TBL] [Abstract][Full Text] [Related]
55. Lysophospholipids enhance taurine release from rat retinal vascular endothelial cells under hypoosmotic stress.
Tachikawa M; Tsuji K; Ikeda S; Hosoya K
Microvasc Res; 2009 Dec; 78(3):332-7. PubMed ID: 19804786
[TBL] [Abstract][Full Text] [Related]
56. Lysophosphatidic acid stimulates prostaglandin E2 production in cultured stromal endometrial cells through LPA1 receptor.
Woclawek-Potocka I; Kondraciuk K; Skarzynski DJ
Exp Biol Med (Maywood); 2009 Aug; 234(8):986-93. PubMed ID: 19491366
[TBL] [Abstract][Full Text] [Related]
57. The role of sphingosine-1-phosphate (S1P) and lysophosphatidic acid (LPA) in regulation of osteoclastic and osteoblastic cells.
Dziak R
Immunol Invest; 2013; 42(7):510-8. PubMed ID: 24004055
[TBL] [Abstract][Full Text] [Related]
58. Endothelial differentiation gene-2 receptor is involved in lysophosphatidic acid-dependent control of 3T3F442A preadipocyte proliferation and spreading.
Pages C; Daviaud D; An S; Krief S; Lafontan M; Valet P; Saulnier-Blache JS
J Biol Chem; 2001 Apr; 276(15):11599-605. PubMed ID: 11152468
[TBL] [Abstract][Full Text] [Related]
59. Gelsolin binding and cellular presentation of lysophosphatidic acid.
Goetzl EJ; Lee H; Azuma T; Stossel TP; Turck CW; Karliner JS
J Biol Chem; 2000 May; 275(19):14573-8. PubMed ID: 10799543
[TBL] [Abstract][Full Text] [Related]
60. Roles of lysophosphatidic acid (LPA) receptor-mediated signaling in cellular functions modulated by endothelial cells in pancreatic cancer cells under hypoxic conditions.
Takai M; Yashiro N; Hara K; Amano Y; Yamamoto M; Tsujiuchi T
Pathol Res Pract; 2024 Mar; 255():155192. PubMed ID: 38367602
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
